Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

14
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
14
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

6.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of dispersion metrics for estimating single-cell transcriptional variability.

PLoS computational biology·2026
Same author

Odyssey of an International Medical Trainee.

Journal of general internal medicine·2025
Same author

The Gilbreth Contribution to Operating Room Management and Surgical Ergonomics.

Surgical innovation·2025
Same author

Comparison of open and laparo-endoscopic repair techniques for patients with bilateral inguinal hernias.

Hernia : the journal of hernias and abdominal wall surgery·2025
Same author

Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes.

Nature genetics·2025
Same author

Comparative analysis of Ficoll-Hypaque and CytoLyt techniques for blood removal in breast cancer malignant effusions: effects on RNA quality and sequencing outcomes.

Journal of the American Society of Cytopathology·2024

Related Experiment Video

Updated: Feb 18, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.0K

Functional germline variants as potential co-oncogenes.

Divyansh Agarwal1,2, Christoph Nowak3,4, Nancy R Zhang1,2

  • 1Department of Genomics and Computational Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA.

NPJ Breast Cancer
|November 28, 2017
PubMed
Summary

Germline variants, or inherited genetic changes, can act as co-oncogenes, influencing cancer development by dictating necessary somatic mutations. Understanding these germline polymorphisms is crucial for targeted cancer therapies.

More Related Videos

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.4K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.4K

Related Experiment Videos

Last Updated: Feb 18, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.0K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.4K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.4K

Area of Science:

  • Genetics
  • Cancer Biology
  • Genomic Medicine

Background:

  • Germline variants influence human traits and disease susceptibility, including cancer.
  • While somatic mutations are the primary focus in cancer biology, germline variants may predispose individuals to specific cancer subtypes.
  • Familial cancer studies suggest germline variants may guide the selection of complementary somatic driver mutations.

Purpose of the Study:

  • To propose that germline polymorphisms function as oncogenic modifiers or co-oncogenes.
  • To highlight the role of germline variants in determining subsequent somatic events required for tumorigenesis.
  • To advocate for integrating germline aberrations with somatic mutations in cancer driver gene identification and therapeutic targeting.

Main Methods:

  • Review of existing literature on germline variants and cancer genetics.
  • Analysis of findings from large-scale breast cancer cohort sequencing studies.
  • Conceptual framework development integrating germline and somatic mutation roles in oncogenesis.

Main Results:

  • Germline variants can significantly modify cancer risk and potentially act as co-oncogenes.
  • The specific germline background may dictate the types of somatic mutations required for malignant transformation.
  • A limited number of recurrent somatic driver mutations in large cohorts suggest diverse oncogenic pathways influenced by germline factors.

Conclusions:

  • Germline polymorphisms should be considered co-oncogenes that influence cancer development.
  • Integrating germline and somatic genetic information is essential for a comprehensive understanding of cancer drivers.
  • This perspective can lead to novel therapeutic strategies targeting both germline and somatic alterations.